Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Vale

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Heart, Lung & Circulation|November 19, 2017
Peripheral Arterial DiseaseSean M Conte, Peter R Vale
Current Pharmaceutical Design|April 8, 2003
Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemiaPeter Schratzberger, Rudolf Kirchmair, Peter R Vale, et al.
Kidney International|February 14, 2002
Angiogenic gene therapy: pre-clinical studies and phase I clinical dataRiyaz Bashir, Peter R Vale, Jeffrey M Isner, et al.
Internal Medicine Journal|December 7, 2019
Drug-eluting versus bare-metal stents for saphenous vein graft lesionsSean M Conte, Daniel S Florisson, Joshua A De Bono, et al.
Circulation|May 1, 2002
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemiaDouglas W Losordo, Peter R Vale, Robert C Hendel, et al.
Journal of Interventional Cardiology|March 25, 2005
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patientsJohn P Reilly, Mark A Grise, F David Fortuin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Heart, Lung & Circulation|November 19, 2017
Peripheral Arterial DiseaseSean M Conte, Peter R Vale
Current Pharmaceutical Design|April 8, 2003
Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemiaPeter Schratzberger, Rudolf Kirchmair, Peter R Vale, et al.
Kidney International|February 14, 2002
Angiogenic gene therapy: pre-clinical studies and phase I clinical dataRiyaz Bashir, Peter R Vale, Jeffrey M Isner, et al.
Internal Medicine Journal|December 7, 2019
Drug-eluting versus bare-metal stents for saphenous vein graft lesionsSean M Conte, Daniel S Florisson, Joshua A De Bono, et al.
Circulation|May 1, 2002
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemiaDouglas W Losordo, Peter R Vale, Robert C Hendel, et al.
Journal of Interventional Cardiology|March 25, 2005
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patientsJohn P Reilly, Mark A Grise, F David Fortuin, et al.
Pageof 1